Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Addition of a Reverse Amide to Methacrylate-Based Dental Materials to Inhibit Microbial Biofilm Formation.

Award Number: R03DE034488
ORGANIZATION: NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 03/10/2025
PERIOD OF PERFORMANCE END DATE: 02/28/2027

Group Awards By:

View Award Description

Addition of a Reverse Amide to Methacrylate-Based Dental Materials to Inhibit Microbial Biofilm Formation. - Secondary caries (SC), the leading reason for the repair or replacement of bonded resin composite fillings worldwide across both pediatric and adult populations, mirrors the etiopathogenesis of primary caries, originating from stagnant Streptococcus mutans biofilms on filling surfaces. For many decades, research efforts on SC prevention have predominantly concentrated on integrating antimicrobial agents into methacrylate-based dental materials (MBM), employing synthetic or natural molecules as well as heavy metal elements. The therapeutic mode of action of these agents, rooted in bacteria-killing mechanisms via surface contact with dental materials and/or drug release, has the potential to disrupt the delicate ecological balance (eubiosis) between commensal (beneficial) and pathogenic (harmful) bacteria within stagnant biofilms, potentially exacerbating dental plaque activity instead of preventing it. Consequently, dentistry faces a shortfall in materials capable of inhibiting disease-associated biofilms while preserving commensal species. Our overarching objective is to leverage the antibacterial properties inherent in the reverse amide 2-aminoimidazole (RA/2-AI) family of small molecules to engineer innovative dental materials. Research findings results have indicated that they covalently interacted with methacrylate and inhibited S. mutans biofilm formation while promoting commensal species when used in water-based solutions. The overall objectives of this NIH grant application are to (i) synthetize a derivative of the RA/2AI family, i.e. 2-amino-N-undecyl-H-imidazole-5-butanamide, hereafter H10, as well as use click chemistry to generate a new methacrylate-based antimicrobial agent containing covalently conjugated H10-HEMA monomer, (ii) formulate MBM self-etch adhesive (SEA) containing both forms of H10, and evaluate their biostability, mechanical characteristics, tooth-material bond strength, and (iii) assess their effectiveness against dysbiotic dental biofilm. The central hypothesis is that MBM-SEA containing H10 sustain mechanical and tooth adhesive properties while inhibiting dysbiotic Streptococcus mutans biofilm formation. The rationale for this project lies in the comprehensive assessment of the biostability, mechanical robustness, tooth-adhesive characteristics, and biofilm inhibition capabilities inherent in SEA containing H10 synthetized forms. The following specific aims are proposed: 1) Evaluate the biostability, mechanical and tooth-material bond strength properties for H10 SEA forms; and 2) Determine in vitro effectiveness SEA against dysbiotic dental biofilm. Under the first aim, HPLC will evaluate H10 release, three-point bending the flexural strength, microtensile bond strength will examine the materials' short- and long-term dentin-enamel adhesion. The research proposed in this application is innovative because 1) it focuses on 2-AI small molecules that inhibits and/or disperse S mutans biofilm, and 2) is amendable to covalent conjugation via click-chemistry with methacrylate-based monomers. The significance of this work lies in its potential to advance dental materials that effectively combat biofilm dysbiosis associated with cavities at the margins of MBM fillings.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $151,926 )
2026	2026	EAST CAROLINA UNIVERSITY	1000 E 5TH ST	GREENVILLE	NC	27858	PITT	USA	Oral Diseases and Disorders Research	001	2	4/15/2026	NON-COMPETING CONTINUATION	$15,193
2026	2026	EAST CAROLINA UNIVERSITY	1000 E 5TH ST	GREENVILLE	NC	27858	PITT	USA	Oral Diseases and Disorders Research	000	2	1/29/2026	NON-COMPETING CONTINUATION	$136,733
														Subtotal = $151,926

Issue Date FY: 2025 ( Subtotal = $164,255 )
2025	2025	EAST CAROLINA UNIVERSITY	1000 E 5TH ST	GREENVILLE	NC	27858	PITT	USA	Oral Diseases and Disorders Research	000	1	3/10/2025	NEW	$164,255
														Subtotal = $164,255

Grand Total All Awards = $316,181

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Addition of a Reverse Amide to Methacrylate-Based Dental Materials to Inhibit Microbial Biofilm Formation.

Award Number: R03DE034488

ORGANIZATION: NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 03/10/2025

PERIOD OF PERFORMANCE END DATE: 02/28/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer